Related Experiment Videos

Pharmacogenetics of antihypertensive treatment: detailing disciplinary dissonance

Donna K Arnett1, Steven A Claas

  • 1University of Alabama at Birmingham, Birmingham AL 55294-0022, USA. arnett@ms.soph.uab.edu

Pharmacogenomics
|August 12, 2009
PubMed

Insights

Hypertension pharmacogenetics aims to predict blood pressure drug responses using genetics. While consistent findings are emerging, large-scale studies are needed for clinical use.

Area of Science:

  • Pharmacogenetics
  • Cardiovascular Medicine
  • Genetics

Background:

  • Hypertension significantly increases cardiovascular risks.
  • Blood pressure control is poor in many patients due to unpredictable drug responses.
  • Current treatment relies on empirical methods.

Purpose of the Study:

  • To review recent studies on genetic predictors of antihypertensive drug response.
  • To assess the progress and challenges in hypertension pharmacogenetics.

Main Methods:

  • Systematic review of 18 pharmacogenetic studies published since 2005.
  • Analysis of gene-treatment associations and response variability.

Main Results:

  • Some consistent gene-treatment combinations are emerging.
  • Findings are often inconsistent and insufficient for clinical translation.
  • Inconsistencies stem from study design, phenotyping, and sample size limitations.

Conclusions:

  • Hypertension pharmacogenetics shows promise but requires further research.
  • Large-scale, high-fidelity studies across diverse populations are essential for clinical application.

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...